2',5'-Bis((1H-imidazol-1-yl)methyl)-[1,1':4',1''-terphenyl]-4,4''-dicarbaldehyde

Catalog No. :
ACEPZH437
CAS No. :
2375720-19-5
Molecular Formula :
C28H22N4O2
Molecular Weight :
446.51

IUPAC Name:2',5'-bis((1H-imidazol-1-yl)methyl)-[1,1':4',1''-terphenyl]-4,4''-dicarbaldehyde

2',5'-Bis((1H-imidazol-1-yl)methyl)-[1,1':4',1''-terphenyl]-4,4''-dicarbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$265.00Login to see priceInquiryInquiry
250mg95%$447.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2',5'-Bis((1H-imidazol-1-yl)methyl)-[1,1':4',1''-terphenyl]-4,4''-dicarbaldehyde
IUPAC Name2',5'-bis((1H-imidazol-1-yl)methyl)-[1,1':4',1''-terphenyl]-4,4''-dicarbaldehyde
Molecular FormulaC28H22N4O2
Molecular Weight446.51
SMILESO=CC=1C=CC(=CC1)C2=CC(=C(C=C2CN3C=NC=C3)C4=CC=C(C=O)C=C4)CN5C=NC=C5
InChI KeyNOEONHUBQBAFJL-UHFFFAOYSA-N
Synonym2',5'-bis((1H-imidazol-1-yl)methyl)-[1,1':4',1''-terphenyl]-4,4''-dicarbaldehyde
CAS No.2375720-19-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACEPZH437 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACEPZH437 route product structure diagram
    ACEPZH4372375720-19-5
Inquiry

2. ACEPZH437 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYVBO782 route compound structure diagram
    ACYVBO78287199-17-5 In Stock
  4. Then
  5. ACEPZH437 route product structure diagram
    ACEPZH4372375720-19-5
Inquiry

Comments (0)